227 filings
Page 4 of 12
8-K
30l07c3 0pi3u22
12 Nov 20
Brickell Biotech Reports Third Quarter 2020 Financial Results
4:08pm
8-K
52n4r
23 Oct 20
Brickell Biotech Announces Pricing of $15.0 Million Underwritten Public Offering
8:12am
8-K
o6ws m3uhirs
6 Oct 20
Regulation FD Disclosure
7:02am
8-K
ebpq5tw 6gbgisbw27t3
25 Sep 20
Japan is the first country to approve sofpironium bromide with commercial launch expected later this year
7:03am
8-K
44mlx7w
1 Sep 20
Departure of Directors or Certain Officers
8:31am
8-K
kmutrb36bn3s xzihk
21 Aug 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
2lccb4tclvj49es8k6
12 Aug 20
Brickell Biotech Reports Second Quarter 2020 Financial Results
4:05pm
8-K/A
kdt4 kqxx
26 Jun 20
Submission of Matters to a Vote of Security Holders
4:23pm
8-K
i57uitqgnr 2o
17 Jun 20
Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering
9:41pm
8-K
e82t2m 4n2yrt7n285f1
15 Jun 20
Data based on registration study in Japan of sofpironium bromide gel, 5% in patients with primary axillary hyperhidrosis
6:34am
8-K
8imtn5
2 Jun 20
Departure of Directors or Certain Officers
4:58pm
8-K
3uhb15q5eqj4qqy4nbw
13 May 20
Brickell Biotech Reports First Quarter 2020
4:07pm
8-K
6fvsva
20 Apr 20
Submission of Matters to a Vote of Security Holders
4:17pm
8-K
l4nrv
14 Apr 20
Entry into a Material Definitive Agreement
5:12pm
8-K
p2x05
3 Apr 20
Other Events
4:25pm
8-K
j7akpr3
18 Mar 20
Other Events
4:57pm
8-K
fnl180
18 Mar 20
Brickell Biotech Reports Fourth Quarter and Full Year 2019
4:14pm
8-K
30zak0xwbn48q yb6
18 Feb 20
Brickell Biotech Announces Settlement of Dispute with Bodor Labs
6:36am
8-K
y58ax9b4efhyb34l
10 Feb 20
Departure of Directors or Certain Officers
4:58pm
8-K/A
tse0h54cy qpuc
10 Feb 20
Index to Financial Statements
4:51pm